NCT02183324View on ClinicalTrials.gov

BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2007

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Low dose of BI 1356 BS

DRUG

Medium dose of BI 1356 BS

DRUG

High dose of BI 1356 BS

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY